Diminished Expression of CYP1A1 in Urethane-induced Lung Tumors in Strain A/J Mice: Analysis by in Situ Hybridization and Immunohistochemical Methods

American Journal of Respiratory Cell and Molecular Biology

Volumn 14, Issue 5, 1996, Pages 444-453

  Forkert, Poh Gek ^a   Jackson, Alan C ^b   Parkinson, Andrew ^b   Chen, Sheng ^b  

^a QUEEN S UNIVERSITY   (Canada)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

3 METHYLCHOLANTHRENE; CYTOCHROME P450; MESSENGER RNA; URETHAN;

A J MOUSE; ANIMAL; ARTICLE; BIOSYNTHESIS; CHEMICALLY INDUCED DISORDER; COMPARATIVE STUDY; DRUG EFFECT; ENZYMOLOGY; FEMALE; GENE EXPRESSION REGULATION; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; LUNG; LUNG TUMOR; METABOLISM; MOUSE; NORTHERN BLOTTING; PATHOLOGY;

ANIMALS; BLOTTING, NORTHERN; CYTOCHROME P-450 ENZYME SYSTEM; FEMALE; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GENE EXPRESSION REGULATION, NEOPLASTIC; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; LUNG; LUNG NEOPLASMS; METHYLCHOLANTHRENE; MICE; MICE, INBRED A; RNA, MESSENGER; URETHANE;

EID: 0030136710     PISSN: 10441549     EISSN: None     Source Type: Journal    
DOI: 10.1165/ajrcmb.14.5.8624249     Document Type: Article

References (39)

1. Haddow, A. 1938. Cellular inhibition and the origin of cancer. Acta Unio. Int. Contra. Cancrum. 3:342-352.
2. Farber, E. 1984. Cellular biochemistry of the stepwise development of cancer with chemicals: G. H. A. Clowes memorial lecture. Cancer Res. 44:5463-5474.
3. Farber, E., and D. S. R. Sarma. 1987. Hepatocarcinogenesis: a dynamic cellular perspective. Lab. Invest. 56:4-22.
4. Farber, E. 1987. Resistance phenotype in the initiation and promotion of chemical hepatocarcinogenesis. Chemica Scripta 27A:131-133.
5. Forkert, P. G., A. Parkinson, L. G. Thaete, and A. M. Malkinson. 1992. Resistance of murine lung tumors to xenobiotic-induced cytotoxicity. Cancer Res. 52:6797-6803.
6. Shimkin, M. B. 1955. Pulmonary tumors in experimental animals. Adv. Cancer Res. 3:223-267.
7. Mostofi, F. K., and Larsen, C. D. 1951. The histopathogenesis of pulmonary tumors induced in strain A mice by urethan. J. Natl. Cancer Inst. 11:1187-1221.
8. Kauffman, S. L., L. Alexander, and L. Sass. 1979. Histologic and ultrastructural features of the Clara cell adenoma of the mouse lung. Lab. Invest. 40:708-716.
9. Forkert, P. G., and E. S. Reynolds. 1982. 1,1-Dichloroethylene-induced pulmonary injury. Exp. Lung Res. 3:57-68.
10. Mahvi, D., H. Bank, and R. Harley. 1977. Morphology of naphthalene-induced bronchiolar lesion. Am. J. Pathol. 86:559-571.
11. Vijeyaratnam, G. S., and B. Corrin. 1971. Experimental paraquat poisoning: a histological and electron-optical study of the changes in the lung. J. Pathol. 103:123-129.
12. Forkert, P. G., M. L. Vessey, S. S. Park, H. V. Gelboin, and S. P. C. Cole. 1989. Cytochromes P-450 in murine lung. An immunohistochemical study with monoclonal antibodies. Drug Metab. Dispos. 17:551-555.
13. 3-450 cDNA nucleotide and amino acid sequences. J. Biol. Chem. 259:10705-10713.
14. Forkert, P. G., S. Chen, and A. C. Jackson. 1995. In situ hybridization analysis of hepatic cytochrome P450 2E1 messenger RNA in mice. Modulation of expression by acetone. Lab. Invest. 72:92-99.
15. Parkinson, A., and B. Gemzik. 1991. Production and characterization of antibodies against rat liver P450 enzymes. Methods Enzymol. 206:233-245.
16. Hsu, S.-M., L. Raine, and H. Fanger. 1981. Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures. J. Histochem. Cytochem. 29:577-580.
17. Smith-Gill, S. J., A. C. Wilson, M. Potter, E. M. Prager, R. J. Feldmann, and C. R. Mainhart. 1982. Mapping the antigenic epitope for a monoclonal antibody against lysozme. J. Immunol. 128:314-322.
18. Tukey, R. H., M. Negishi, and D. W. Neben. 1982. Quantitation of hepatic cytochrome P1-450 mRNA with the use of a cloned DNA probe. Effects of various P-450 inducers in C57BL/6N and DBA/2N mice. Mol. Pharmacol. 22:779-786.
19. 1-450 and P3-450 genes. Dev. Biol. 112:177-184.
20. Whitlock, J. P., Jr. 1986. The regulation of cytochrome P-450 gene expression. Annu. Rev. Pharmacol. Toxicol. 26:333-369.
21. Malkinson, A. M. 1991. Genetic studies on lung tumor susceptibility and histogenesis in mice. Environ. Health Perpect. 93:149-159.
22. Thaete, L. G., W. T. Gunning, G. D. Stoner, and A. M. Malkinson. 1987. Cellular derivation of lung tumors in sensitive and resistant strains of mice: results at 28 and 56 weeks after urethan treatment. J. Natl. Cancer Inst. 78:743-749.
23. Nettesheim, P., and A. S. Hammons. 1971. Induction of squamous cell carcinomas in the respiratory tract of mice. J. Natl. Cancer Inst. 47:697-701.
24. Rehm, S., and G. J. Kelloff. 1991. Histologic characterization of mouse bronchiolar cell hyperplasia, metaplasia, and neoplasia induced intratracheally by 3-methylcholanthrene. Exp. Lung Res. 17:229-244.
25. Leuehtenberger, C., and R. Leuchtenberger. 1970. Einfluß chronischer Inhalationen von frischem Zigaarettenrauch und dessen Gasphase auf die Entwicklung von Lungentumoren bei Snell's Mäusen. 1970. Z. Präventivmed. 17:457-462.
26. Anttila, S., E. Hietanen, H. Vainio, A.-M. Camus, H. V. Gelboin, S. S. Park, L. Heikkilä, A. Karjalainen, and H. Bartsch. 1991. Smoking and peripheral type of cancer are related to high levels of pulmonary cytochrome P450IA in lung cancer patients. Int. J. Cancer 47:681-685.
27. Vena, J. E., T. E. Byers, D. Cookfair, and M. Swanson. 1985. Occupation and lung cancer risk. An analysis by histologic subtypes. Cancer 56:910-917.
28. Anttila, S., H. Vainio, E. Hietanen, A.-M. Camus, C. Malaveille, G. Brun, K. Husgafvel-Pursiainen, L. Heikkilä, A. Karjalainen, and H. Bartsch. 1992. Immunohistochemical detection of pulmonary cytochrome P450IA and metabolic activities associated with P4501A1 and P450IA2 isozymesin lung cancer patients. Environ. Health Perspect. 98:179-182.
29. Petruzzelli, S., A. M. Camus, L. Carrozzi, L. Ghelarducci, M. Rindi, G. Menconi, C. A. Angeletti, M. Ahotupa, E. Hietanen, A. Aitio, R. Saracci, H. Bartsch, and C. Giuntini. 1988. Long-lasting effects of tobacco smoking on pulmonary drug-metabolizing enzymes: a case-control study on lung cancer patients. Cancer Res. 48:4695-4700.
30. Anderson, L. M., J. M. Ward, S. S. Park, A. B. Jones, J. L. Junker, H. V. Gelboin, and J. M. Rice. 1988. Immunohistochemical determination of inducibility phenotype with a monoclonal antibody to a methylcholanthrene-inducible isozyme of cytochrome P-450. Cancer Res 47:6079-6085.
31. Overby, L. H., S. Nishio, A. Weir, G. T. Carver, C. G. Plopper, and R. M. Philpot. 1992. Distribution of cytochrome P450 1A1 and NADPH-cytochrome P450 reductase in lungs of rabbits treated with 2,3,8-tetra-chlorodibenzo-p-dioxin: ultrastructural immunolocalization and in situ hybridization. Mol. Pharmacol. 41:1039-1046.
32. Pairon, J.-C., N. Trabelsi, A. Buard, J. Fleury-Feith, C.-M. Bachelet, F. Poron, P. Beaune, P. Brochard, and P. Laurent. 1994. Cell localization and regulation of expression of cytochrome P450 1A1 and 2B1 in rat lung after induction with 3-methylcholanthrene using mRNA hybridization and immunohistochemistry. Am. J. Respir. Cell Mol. Biol. 11:386-396.
33. Ji, C. M., C. G. Plopper, H. P. Witschi, and K. E. Pinkerton. 1994. Exposure to sidestream cigarette smoke alters bronchiolar epithelial cell differentiation in the postnatal rat lung. Am. J. Respir. Cell Mol. Biol. 11:312-320.
34. Kellerman, G., C. R. Shaw, and M. Luyten-Kellerman. 1973. Aryl hydrocarbon hydroxylase inducibility and bronchogenic carcinoma. N. Engl. J. Med. 289:934-937.
35. Kouri, R. E., C. E. McKinney, D. J. Slomiany, D. R. Snodgrass, N. P. Wray, and T. L. McLemore. 1982. Positive correlation between aryl hydrocarbon hydroxylase activity and primary lung cancer as analyzed in cryopreserved lymphocytes. Cancer Res. 42:5030-5037.
36. 6-etheno-adenosine. Chem. Res. Toxicol. 4:413-421.
37. Guengerich, F. P., D.-H. Kim, and M. Iwasaki 1991. Role of human cytochrome P-450 IIE1 in the oxidation of many low molecular weight cancer suspects. Chem. Res. Toxicol. 4:168-179.
38. 6-Ethenoadenosine formation, mutagenicity and murine tumor induction as indicators of the generation of an electrophile epoxide metabolite of the closely related carcinogens ethyl carbamate (urethane) and vinyl carbamate. Carcinogenesis 11:463-473.
39. Park, K.-K., A. Liem, B. C. Stewart, and J. A. Miller. 1993. Vinyl carbamate epoxide, a major strong electrophilic, mutagenic and carcinogenic metabolite of vinyl carbamate and ethyl carbamate (urethane). Carcinogenesis 14:441-450.